MedPath

通化中盛药业有限公司

Ownership
-
Established
2014-06-24
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

79

NMPA:79

Drug Approvals

Sophoridine Hydrochloride Injection

Product Name
盐酸槐定碱注射液
Approval Number
国药准字H20051681
Approval Date
Mar 1, 2024
NMPA

Compund Honeysuckle Stem and Aspirin Tablets

Product Name
复方忍冬藤阿司匹林片
Approval Number
国药准字H22024113
Approval Date
Mar 11, 2022
NMPA

男宝胶囊

Approval Number
国药准字Z22020319
Approval Date
Dec 6, 2021
NMPA

参桂再造丸

Approval Number
国药准字Z22020261
Approval Date
Dec 6, 2021
NMPA

麝香接骨胶囊

Approval Number
国药准字Z22020317
Approval Date
Oct 19, 2021
NMPA

乙肝扶正胶囊

Approval Number
国药准字Z22020310
Approval Date
Oct 18, 2021
NMPA

乙肝解毒胶囊

Approval Number
国药准字Z22020311
Approval Date
Oct 18, 2021
NMPA

感特灵片

Approval Number
国药准字Z20025962
Approval Date
Oct 18, 2021
NMPA

感冒清胶囊

Approval Number
国药准字Z22020233
Approval Date
Oct 18, 2021
NMPA

大活络丸

Approval Number
国药准字Z22020259
Approval Date
Sep 29, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.